LEUKEMIA, MYELOID, CHRONIC
Clinical trials for LEUKEMIA, MYELOID, CHRONIC explained in plain language.
Never miss a new study
Get alerted when new LEUKEMIA, MYELOID, CHRONIC trials appear
Sign up with your email to follow new studies for LEUKEMIA, MYELOID, CHRONIC, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New hope for leukemia patients out of options
Disease control Recruiting nowThis early-stage study is testing a new oral medication called HQP1351 for patients with chronic myeloid leukemia (CML) or a type of acute lymphoblastic leukemia (Ph+ ALL) that has stopped responding to or cannot tolerate standard treatments. The main goals are to find a safe and…
Matched conditions: LEUKEMIA, MYELOID, CHRONIC
Phase: PHASE1 • Sponsor: Ascentage Pharma Group Inc. • Aim: Disease control
Last updated Apr 02, 2026 00:26 UTC
-
Two-Pronged attack: new leukemia drug strategy aims for deeper remission
Disease control Recruiting nowThis study is testing a new drug, asciminib, for adults newly diagnosed with a slow-growing type of blood cancer called chronic myeloid leukemia (CML). The goal is to see if asciminib alone can drive the cancer into a very deep remission. If it doesn't work well enough after two …
Matched conditions: LEUKEMIA, MYELOID, CHRONIC
Phase: PHASE2 • Sponsor: Augusta University • Aim: Disease control
Last updated Mar 30, 2026 14:29 UTC